News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,231 Results
Type
Article (5012)
Company Profile (17)
Press Release (220202)
Section
Business (82200)
Career Advice (461)
Deals (15041)
Drug Delivery (8)
Drug Development (19061)
Employer Resources (30)
FDA (3676)
Job Trends (3901)
News (120105)
Policy (7503)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14773)
ALS (20)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3694)
Artificial intelligence (41)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (450)
Cardiovascular disease (24)
Career advice (393)
Career pathing (3)
CAR-T (31)
Cell therapy (103)
Cervical cancer (2)
Clinical research (16034)
Collaboration (170)
Compensation (170)
Complete response letters (2)
COVID-19 (301)
CRISPR (7)
C-suite (105)
Cystic fibrosis (16)
Data (519)
Depression (5)
Diabetes (42)
Diagnostics (2041)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40837)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37783)
Executive appointments (313)
FDA (3928)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (185)
Gene editing (15)
Generative AI (2)
Gene therapy (53)
GLP-1 (108)
Government (411)
Guidances (17)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7822)
IRA (3)
Job creations (1121)
Job search strategy (360)
Kidney cancer (7)
Labor market (5)
Layoffs (100)
Leadership (5)
Legal (2333)
Liver cancer (17)
Lung cancer (54)
Lymphoma (31)
Management (10)
Manufacturing (49)
MASH (28)
Medical device (3860)
Medtech (3861)
Mergers & acquisitions (7424)
Metabolic disorders (122)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (340)
NextGen: Class of 2025 (1674)
Non-profit (727)
Northern California (932)
Now hiring (3)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (13)
Pancreatic cancer (14)
Parkinson's disease (27)
Partnered (4)
Patents (21)
Patient recruitment (30)
Peanut (5)
People (24594)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4780)
Phase II (6963)
Phase III (5549)
Pipeline (559)
Policy (9)
Postmarket research (625)
Preclinical (1872)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (68)
Real estate (1874)
Recruiting (8)
Regulatory (5118)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (28)
Series B (23)
Sickle cell disease (7)
Southern California (706)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1008)
Stomach cancer (1)
Supply chain (10)
Tariffs (4)
United States (7069)
Vaccines (36)
Venture capitalists (2)
Weight loss (21)
Women's health (1)
Date
Today (42)
Last 7 days (200)
Last 30 days (698)
Last 365 days (9982)
2025 (3046)
2024 (11027)
2023 (13193)
2022 (18659)
2021 (19678)
2020 (18238)
2019 (13205)
2018 (10206)
2017 (10002)
2016 (9156)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11457)
Australia (1609)
California (1954)
Canada (702)
China (72)
Colorado (83)
Connecticut (92)
Delaware (30)
Europe (24518)
Florida (279)
Georgia (34)
Idaho (23)
Illinois (113)
India (7)
Indiana (64)
Iowa (2)
Japan (72)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (221)
Massachusetts (1564)
Michigan (85)
Minnesota (139)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (15)
New Jersey (561)
New Mexico (5)
New York (472)
North Carolina (328)
North Dakota (2)
Northern California (932)
Ohio (57)
Oklahoma (5)
Oregon (4)
Pennsylvania (347)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (5)
Southern California (706)
Tennessee (40)
Texas (228)
Utah (60)
Virginia (46)
Washington D.C. (9)
Washington State (174)
West Virginia (2)
Wisconsin (22)
225,231 Results for "tearlab corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
TearLab® Announces Corporate Name Change to Trukera™ Medical, Positions Company for Further Expansion in Corneal Health
TearLab® Corporation, the global leader in ophthalmic point-of-care diagnostics, announced that it will be expanding its position in corneal health under the new name Trukera™ Medical.
September 7, 2022
·
3 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Deals
TearLab Corporation Confirms Merger Discussions
In light of recent market rumors, TearLab Corporation confirmed that TearLab is engaged in advanced discussions regarding a potential business combination whereby TearLab will be acquired at a price per share equal to $0.0586.
May 7, 2020
·
2 min read
Press Releases
Quantum BioPharma Corporate Update
April 21, 2025
·
4 min read
Deals
TearLab Closes Acquisition By Accelmed Partners
TearLab Corporation (TearLab), a leader in diagnostics for dry eye disease (DED), today announced their acquisition by Accelmed Partners II (AP-II). As a newly formed private company, TearLab is now positioned to pursue further devel
July 9, 2020
·
2 min read
Press Releases
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
April 24, 2025
·
2 min read
Business
TearLab Corporation Reports Fourth Quarter and Full Year 2019 Financial Results
TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the fourth quarter and twelve months ended December 31, 2019
March 5, 2020
·
5 min read
Press Releases
CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller
April 17, 2025
·
7 min read
Biotech Beach
TearLab Resubmits 510(k) for U.S. FDA Clearance of the TearLab Discovery™ MMP-9 Test
TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmission of its 510(k) application for the potential clearance of its TearLab Discovery™ MMP-9 Test, the Company’s next-generation in-vitro diagnostic testing system.
April 22, 2020
·
2 min read
Business
TearLab Appoints Adam Szaronos as Chief Commercial Officer
TearLab Corporation (TearLab), an eye care medical device firm marketing lab-on-a-chip diagnostic technologies at the point-of-care, today announced the appointment of Adam Szaronos to the position of Chief Commercial Officer (CCO).
July 28, 2020
·
2 min read
1 of 22,524
Next
